News & insights

IOC x ZSCXH x DCHA press conference

01.01.1970

On 2 March 2022, Zhongshan Chenxinghai Hospital, Hong Kong Integrated Oncology Centre (HKIOC), and DCH Auriga announced the strategic cooperation in support of a National State Council initiative to provide Hong Kong-approved medical treatments to Greater Bay Area (GBA) patients.

Under the strategic partnership, DCH Auriga and HKIOC will support Zhongshan Chenxinghai Hospital to offer the newly available treatments, with Auriga supporting the product supply chain and HKIOC sharing its expertise through joint Multi-Disciplinary Teams for individual cases. DCH Auriga also rolled out a e-learning platform GBAHealthConnect.com for HK-Macau-and GBA cities healthcare professionals, to facilitate GBA HCPs for advanced clinical experience sharing and enable them with better options to improve patients’ outcomes.

The strategic collaboration ultimately provides a model for the initiative’s adoption across GBA cities and contributes towards the shared vision of a “Healthy Bay Area.” At Auriga, we never stop striving for better patient outcome. To learn more about the cross-boundary initiative and help us support patients in the Greater Bay Area, please contact us via [email protected] or (852) 3619 2800 for more details.

 

 

#DCHAuriga #Healthcare #ColdChain #GBAHealthConnect #GreaterBayArea

Back to news and insights

Explore Auriga’s success stories

THE BIG DAY! The arrival of Fosun Pharma BioNTech's COMIRNATY Covid-19 vaccines on 27 February, 2021
THE BIG DAY! The arrival of Fosun Pharma BioNTech's COMIRNATY Covid-19 vaccines on 27 February, 2021
   
DCH Auriga being exclusive distributor of BioNTech Covid-19 vaccine in Hong Kong
DCH Auriga being exclusive distributor of BioNTech Covid-19 vaccine in Hong Kong
 
Partners in cancer therapy
Partners in cancer therapy
In June 2012, the Auriga Hong Kong team saw an opportunity to help a biotech company offering cancer therapy products meet the needs of their growing business. The company was struggling with a local distributor that could not meet their sales KPIs or the need for one-working day delivery.  Our teams understood the challenges of managing a growing business, offered strong channel relationships…
GREEN | CLEAN | LEAN. DCH AURIGA THAILAND SCALES UP COLD CHAIN CAPACITY VERTICALLY
GREEN | CLEAN | LEAN. DCH AURIGA THAILAND SCALES UP COLD CHAIN CAPACITY VERTICALLY
With key market presence and infrastructure in place, DCH Auriga ensures their partners business needs are served regionally and supports businesses to access the fragmented market using integrated technology platforms and processes, quality access and their comprehensive distribution network. At DCH Auriga we are always looking into better warehousing storage and efficiency solutions that provides…
DCH Auriga rolls out state-of-the-art Warehouse Management System
DCH Auriga rolls out state-of-the-art Warehouse Management System
Hong Kong. DCH Auriga announced today that it has successfully implemented the latest version of JDA Warehouse Management System (WMS) and has fully integrated it into its ERP system. The Asian-based integrated market management leader who specialises in healthcare has now successfully gone live with JDA WMS in two of its distribution centres located in Singapore and in Hong Kong. As part of its continued…
DCH Auriga selected as the logistics partner to distribute the Fosun Pharma-BioNTech COVID-19 vaccine in Hong Kong
DCH Auriga selected as the logistics partner to distribute the Fosun Pharma-BioNTech COVID-19 vaccine in Hong Kong
DCH Auriga, one of the largest healthcare distributors in Hong Kong with decades of experience managing sophisticated pharmaceutical supply chains, is pleased to announce it has been selected to manage the storage and delivery of the Fosun Pharma-BioNTech BNT162b2 vaccine in Hong Kong as the exclusive logistics partner of Shanghai Fosun Pharmaceutical (Group) Co., Limited (Stock Code: 600196.SH, 02196.HK)…
Health-at-Home Care with Baxter
Health-at-Home Care with Baxter
Auriga Hong Kong supports Baxter with home delivery for chronic care Sometimes, opportunity knocks on the door. In 2015, Baxter appointed Auriga as their sole distributor of renal dialysis solution in Hong Kong - a complex home delivery healthcare product which appeared to be a fairly new market for Auriga to explore. Baxter's operations included receiving, picking and delivering prescription…